$25 Million Way To Go

Associate reporter Kristi Coale examines a $25 million deal between Swiss biotech giant Novartis and University of California at Berkeley’s Department of Plant and Microbial Biology, which frees faculty and students from the need to pursue individual funding. The investigation raises troubling questions about how the deal will affect university autonomy and impartiality, as well as control over gene patents.

Like our content? Help us do more.

Support Us